The melanocortin system in control of inflammation

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 1840-1853

  Catania, Anna ^a   Lonati, Caterina ^a   Sordi, Andrea ^a   Carlin, Andrea ^a   Leonardi, Patrizia ^a   Gatti, Stefano ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

, , melanocyte stimulating hormone ( , , MSH); Acute respiratory distress syndrome (ARDS); Adhesion molecules; Adrenocorticotropic hormone (ACTH); Allergic inflammation; Brain injury; Cyclic 3 ,5 adenosine monophosphate (cAMP); Cytokines; Endothelial cells; Fibroblast; G protein coupled receptors (GPCRs); Gout; Inflammatory bowel disease (IBD); Keratinocyte; Lymphocyte; Macrophage; Melanocortin receptor accessory protein (MRAP); Melanocortin receptors; Melanocyte; Monocyte; Neuroprotection; Neutrophil; Nuclear factor B (NF B); Pro opiomelanocortin (POMC); Reperfusion injury; Rheumatoid arthritis; Septic shock; Signal transducers and activator of transcription (STAT); Suppressors of cytokine signaling (SOCS); Tumor necrosis factor (TNF )

Indexed keywords

CORTICOTROPIN; INTERMEDIN; MELANOCORTIN; MELANOCORTIN RECEPTOR; PROOPIOMELANOCORTIN;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; BRAIN REGION; CELL MIGRATION; ENTERITIS; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY CELL; NEUROPROTECTION; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; ANIMAL; BIOLOGICAL MODEL; BRAIN; DRUG EFFECT; HUMAN; METABOLISM; PATHOLOGY;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BRAIN; HUMANS; INFLAMMATION; MELANOCORTINS; MODELS, BIOLOGICAL; PRO-OPIOMELANOCORTIN; RECEPTORS, MELANOCORTIN; SIGNAL TRANSDUCTION;

EID: 78349285554     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.173     Document Type: Review

References (145)

1. Catania, A. (2007) The melanocortin system in leukocyte biology. J. Leukoc. Biol. 81, 383-392.
2. Heinig, J.A., Keeley, F.W., Robson, P., Sower, S.A., and Youson, J.H. (1995) The appearance of proopiomelanocortin early in vertebrate evolution: cloning and sequencing of POMC from a Lamprey pituitary cDNA library. Gen. Comp. Endocrinol. 99, 137-144.
3. Singh, A., Haslach, E.M., and Haskell-Luevano, C. (2010) Structure-activity relationships (SAR) of melanocortin and agouti-related (ARP) peptides. In Melanocortins: Multiple Actions and Therapeutic Potential. Catania, A., Ed. Landes Bioscience and Springer Science + Business Media, New York. pp. 1-18.
4. Seidah, N.G. and Chretien, M. (1994) Pro-protein convertases of subtilisin/kexin family. Methods Enzymol. 244, 175-188.
5. Benjannet, S., Rondeau, N., Day, R., Chretien, M., and Seidah, N.G. (1991) PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc. Natl. Acad. Sci. U. S. A. 88, 3564-3568.
6. Slominski, A., Wortsman, J., Luger, T., Paus, R., and Solomon, S. (2000) Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 80, 979-1020.
7. Holder, J.R. and Haskell-Luevano, C. (2004) Melanocortin ligands: 30 years of structure-activity relationship (SAR) studies. Med. Res. Rev. 24, 325-356.
8. Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., and Cone, R.D. (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251.
9. Chhajlani, V. and Wikberg, J.E.S. (1992) Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309, 417-420.
10. Mountjoy, K.G. (2000) Cloning of the melanocortin receptors. In The Melanocortin Receptors. Cone, R.D., Ed. Humana Press, Totowa, NJ. pp. 209-235.
11. Roselli-Rehfuss, L., Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., Low, M.J., Tatro, J.B., Entwistle, M.L., Simerly, R.B., and Cone, R.D. (1993) Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. U. S. A. 90, 8856-8860.
12. Mountjoy, K.G., Mortrud, M.T., Low, M.J., Simerly, R.B., and Cone, R.D. (1994) Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8, 1298-1308.
13. Gantz, I., Konda, Y., Tashiro, T., Shimoto, Y., Miwa, H., Munzert, G., Watson, S.J., DelValle, J., and Yamada, T. (1993) Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268, 8246-8250. (Pubitemid 23120413)
14. Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S.J., DelValle, J., and Yamada, T. (1993) Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268, 15174-15179. (Pubitemid 23206671)
15. Gantz, I., Shimoto, Y., Konda, Y., Miwa, H., Dickinson, C.J., and Yamada, T. (1994) Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 200, 1214-1220.
16. Catania, A., Gatti, S., Colombo, G., and Lipton, J.M. (2004) Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 56, 1-29.
17. Hunt, G., Donatien, P.D., Lunec, J., Todd, C., Kyne, S., and Thody, A.J. (1994) Cultured human melanocytes respond to MSH peptides and ACTH. Pigment Cell Res. 7, 217-221.
18. Abdel-Malek, Z., Swope, V.B., Suzuki, I., Akcali, C., Harriger, M.D., Boyce, S.T., Urabe, K., and Hearing, V.J. (1995) Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc. Natl. Acad. Sci. U. S. A. 92, 1789-1793.
19. Mountjoy, K.G., Bird, I.M., Rainey, W.E., and Cone, R.D. (1994) ACTH induces up-regulation of ACTH receptor mRNA in mouse and human adrenocortical cell lines. Mol. Cell. Endocrinol. 99, R17-20.
20. Cone, R.D. (2006) Studies on the physiological functions of the melanocortin system. Endocr. Rev. 27, 736-749.
21. Leoni, G., Patel, H.B., Sampaio, A.L., Gavins, F.N., Murray, J.F., Grieco, P., Getting, S.J., and Perretti, M. (2008) Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion. FASEB J. 22, 4228-4238.
22. Getting, S.J. and Perretti, M. (2000) MC3-R as a novel target for antiinflammatory therapy. Drug News Perspect. 13, 19-27.
23. Mountjoy, K.G. (2010) Distribution and function of melanocortin receptors within the brain. In Melanocortins: Multiple Actions and Therapeutic Potential. Catania, A., Ed. Landes Bioscience and Springer Science + Business Media, New York. pp. 29-48.
24. Catania, A. (2008) Neuroprotective actions of melanocortins: a therapeutic opportunity. Trends Neurosci. 31, 353-360.
25. Chen, A.S., Marsh, D.J., Trumbauer, M.E., Frazier, E.G., Guan, X.M., Yu, H., Rosenblum, C.I., Vongs, A., Feng, Y., Cao, L., Metzger, J.M., Strack, A.M., Camacho, R.E., Mellin, T.N., Nunes, C.N., Min, W., Fisher, J., Gopal-Truter, S., MacIntyre, D.E., Chen, H.Y., and Van Der Ploeg, L.H. (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26, 97-102.
26. Butler, A.A., Kesterson, R.A., Khong, K., Cullen, M.J., Pelleymounter, M.A., Dekoning, J., Baetscher, M., and Cone, R.D. (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141, 3518-3521.
27. Huszar, D., Lynch, C.A., Fairchild-Huntress, V., Dunmore, J.H., Smith, F.J., Kesterson, R.A., Boston, B.A., Fang, Q., Berkemeir, L.R., Gu, W., Cone, R.D., Campfield, L.A., and Lee, F. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131-141.
28. Chen, W., Kelly, M.A., Opitz-Araya, X., Thomas, R.E., Low, M.J., and Cone, R.D. (1997) Exocrine gland dysfunction in MC5-r deficient mice: evidence for coordinated regulation of exocrine gland functions by melanocortin peptides. Cell 91, 789-798. (Pubitemid 28007735)
29. Buggy, J.J. (1998) Binding of α-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway. Biochem. J. 331(Pt 1), 211-216.
30. Taylor, A. and Namba, K. (2001) In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide α-melanocyte stimulating hormone (α-MSH). Immunol. Cell Biol. 79, 358-367.
31. Hruby, V.J., Wilkes, B.C., Cody, W.L., Sawyer, T.K., and Hadley, M.E. (1984) Melanotropins: structural, conformational and biological considerations in the development of superpotent and superprolonged analogs. Peptide Protein Rev. 3, 1-64.
32. Haskell-Luevano, C., Sawyer, T.K., Hendrata, S., North, C., Panahinia, L., Stum, M., Staples, D.J., Castrucci, A.M., Hadley, M.E., and Hruby, V.J. (1996) Truncation studies of α-melanotropin peptides identifies tripeptide analogues exhibiting prolonged agonist bioactivity. Peptides 17, 995-1002.
33. Lu, D., Willard, D., Patel, I.R., Kadwell, S., Overton, L., Kost, T., Luther, M., Chen, W., Yowchik, R.P., Wilkison, W.O., and Cone, R.D. (1994) Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371, 799-802.
34. Ollmann, M.M., Wilson, B.D., Yang, Y.-K., Kerns, J.A., Chen, Y., Gantz, I., and Barsh, G.S. (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278, 135-138.
35. Brady, A.E. and Limbird, L.E. (2002) G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. Cell. Signal. 14, 297-309.
36. Sebag, J.A. and Hinkle, P.M. (2009) Opposite effects of the melanocortin-2 (MC2) receptor accessory protein MRAP on MC2 and MC5 receptor dimerization and trafficking. J. Biol. Chem. 284, 22641-22648.
37. Hinkle, P.M. and Sebag, J.A. (2009) Structure and function of the melanocortin2 receptor accessory protein (MRAP). Mol. Cell. Endocrinol. 300, 25-31.
38. Roy, S., Rached, M., and Gallo-Payet, N. (2007) Differential regulation of the human adrenocorticotropin receptor [melanocortin-2 receptor (MC2R)] by human MC2R accessory protein isoforms α and β in isogenic human embryonic kidney 293 cells. Mol. Endocrinol. 21, 1656-1669. (Pubitemid 47001089)
39. He, L., Eldridge, A.G., Jackson, P.K., Gunn, T.M., and Barsh, G.S. (2003) Accessory proteins for melanocortin signaling: attractin and mahogunin. Ann. N. Y. Acad. Sci. 994, 288-298.
40. Chan, L.F., Webb, T.R., Chung, T.T., Meimaridou, E., Cooray, S.N., Guasti, L., Chapple, J.P., Egertova, M., Elphick, M.R., Cheetham, M.E., Metherell, L.A., and Clark, A.J. (2009) MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Proc. Natl. Acad. Sci. U. S. A. 106, 6146-6151.
41. Metherell, L.A., Chapple, J.P., Cooray, S., David, A., Becker, C., Ruschendorf, F., Naville, D., Begeot, M., Khoo, B., Nurnberg, P., Huebner, A., Cheetham, M.E., and Clark, A.J. (2005) Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat. Genet. 37, 166-170.
42. Sebag, J.A. and Hinkle, P.M. (2009) Opposite effects of melanocortin-2 (MC2) receptor accessory protein MRAP on C2 and MC5 receptor dimerization and trafficking. J. Biol. Chem. 284, 22641-22648.
43. Perez-Oliva, A.B., Olivares, C., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2009) Mahogunin ring finger-1 (MGRN1) E3 ubiquitin ligase inhibits signaling from melanocortin receptor by competition with Gαs. J. Biol. Chem. 284, 31714-31725.
44. Eves, P., Haycock, J., Layton, C., Wagner, M., Kemp, H., Szabo, M., Morandini, R., Ghanem, G., Garcia-Borron, J.C., Jimenez-Cervantes, C., and Mac Neil, S. (2003) Anti-inflammatory and anti-invasive effects of α-melanocyte-stimulating hormone in human melanoma cells. Br. J. Cancer 89, 2004-2015.
45. Konda, Y., Gantz, I., DelValle, J., Shimoto, Y., Miwa, H., and Yamada, T. (1994) Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J. Biol. Chem. 269, 13162-13166.
46. Eves, P.C. and Haycock, J.W. (2010) Melanocortin signalling mechanisms. In Melanocortins: Multiple Actions and Therapeutic Potential. Catania, A., Ed. Landes Bioscience and Springer Science + Business Media, New York. pp. 19-28.
47. Elliott, R.J., Szabo, M., Wagner, M.J., Kemp, E.H., MacNeil, S., and Haycock, J.W. (2004) α-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J. Invest. Dermatol. 122, 1010-1019. (Pubitemid 38581004)
48. Manna, S.K. and Aggarwal, B.B. (1998) α-Melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-κB activation induced by various inflammatory agents. J. Immunol. 161, 2873-2880.
49. Gupta, A.K., Diaz, R.A., Higham, S., and Kone, B.C. (2000) α-MSH inhibits induction of C/EBPβ-DNA binding activity and NOS2 gene transcription in macrophages. Kidney Int. 57, 2239-2248.
50. Haddad, J.J., Lauterbach, R., Saade, N.E., Safieh-Garabedian, B., and Land, S.C. (2001) α-Melanocyte-related tripeptide, Lys-d-Pro-Val, ameliorates endotoxin-induced nuclear factor κB translocation and activation: evidence for involvement of an interleukin-1 193-195 receptor antagonism in the alveolar epithelium. Biochem. J. 355, 29-38.
51. Hassoun, H.T., Zou, L., Moore, F.A., Kozar, R.A., Weisbrodt, N.W., and Kone, B.C. (2002) α-Melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury. Am. J. Physiol. Gastrointest. Liver Physiol. 282, G1059-1068.
52. Haycock, J.W., Wagner, M., Morandini, R., Ghanem, G., Rennie, I.G., and Mac Neil, S. (1999) α-Melanocyte-stimulating hormone inhibits NF-κB activation in human melanocytes and melanoma cells. J. Invest. Dermatol. 113, 560-566. (Pubitemid 29489617)
53. Ichiyama, T., Campbell, I.L., Furukawa, S., Catania, A., and Lipton, J.M. (1999) Autocrine α-melanocyte-stimulating hormone inhibits NF-κB activation in human glioma. J. Neurosci. Res. 58, 684-689.
54. Ichiyama, T., Okada, K., Campbell, I.L., Furukawa, S., and Lipton, J.M. (2000) NF-κB activation is inhibited in human pulmonary epithelial cells transfected with α-melanocyte-stimulating hormone vector. Peptides 21, 1473-1477.
55. Mandrika, I., Muceniece, R., and Wikberg, J.E. (2001) Effects of melanocortin peptides on lipopolysaccharide/interferon-γ-induced NF-κB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action. Biochem. Pharmacol. 61, 613-621.
56. May, M.J. and Ghosh, S. (1998) Signal transduction through NF-kB. Immunol. Today 19, 80-88.
57. Ichiyama, T., Zhao, H., Catania, A., Furukawa, S., and Lipton, J.M. (1999) α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation. Exp. Neurol. 157, 359-365.
58. Bohm, M., Schulte, U., Kalden, H., and Luger, T.A. (1999) α-Melanocyte-stimulating hormone modulates activation of NF-κB and AP-1 and secretion of interleukin-8 in human dermal fibroblasts. Ann. N. Y. Acad. Sci. 885, 277-286.
59. Hill, R.P., MacNeil, S., and Haycock, J.W. (2006) Melanocyte stimulating hormone peptides inhibit TNF-α signaling in human dermal fibroblast cells. Peptides 27, 421-430. (Pubitemid 43162914)
60. Kalden, D.H., Scholzen, T., Brzoska, T., and Luger, T.A. (1999) Mechanisms of the antiinflammatory effects of α-MSH. Role of transcription factor NF-κB and adhesion molecule expression. Ann. N. Y. Acad. Sci. 885, 254-261.
61. Brzoska, T., Kalden, D.H., Scholzen, T., and Luger, T.A. (1999) Molecular basis of the α-MSH/IL-1 antagonism. Ann. N. Y. Acad. Sci. 885, 230-238.
62. Teare, K.A., Pearson, R.G., Shakesheff, K.M., Raisman, G., and Haycock, J.W. (2003) Alpha-MSH inhibits inflammatory signalling in olfactory ensheathing cells. Neuroreport 14, 2171-2175.
63. Teare, K.A., Pearson, R.G., Shakesheff, K.M., and Haycock, J.W. (2004) Alpha-MSH inhibits inflammatory signalling in Schwann cells. Neuroreport 15, 493-498.
64. Barcellini, W., Colombo, G., La Maestra, L., Clerici, G., Garofalo, L., Brini, A.T., Lipton, J.M., and Catania, A. (2000) α-Melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes. J. Leukoc. Biol. 68, 693-699.
65. Etemad-Moghadam, B., Chen, H., Yin, P., Aziz, N., and Hedley, M.L. (2002) Inhibition of NF-κB activity by plasmid expressed αMSH peptide. J. Neuroimmunol. 125, 23-29. (Pubitemid 34327450)
66. Taylor, A.W. (2005) The immunomodulating neuropeptide α-melanocyte-stimulating hormone (α-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. J. Neuroimmunol. 162, 43-50.
67. Cooper, A., Robinson, S.J., Pickard, C., Jackson, C.L., Friedmann, P.S., and Healy, E. (2005) α-Melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status. J. Immunol. 175, 4806-4813. (Pubitemid 41362024)
68. Chang, S.H., Jung, E.J., Lim, D.G., Park, Y.H., Wee, Y.M., Kim, J.H., Kim, Y.H., Choi, M.Y., Koo, S.K., Choi, K.D., Han, D.J., and Kim, S.C. (2008) Anti-inflammatory action of α-melanocyte stimulating hormone (α-MSH) in anti-CD3/CD28-mediated spleen and CD4(+)CD25(-) T cells and a partial participation of IL-10. Immunol. Lett. 118, 44-48.
69. Rennalls, L.P., Seidl, T., Larkin, J.M., Wellbrock, C., Gore, M.E., Eisen, T., and Bruno, L. (2010) The melanocortin receptor agonist NDP-MSH impairs the allostimulatory function of dendritic cells. Immunology 129, 610-619.
70. Getting, S.J., Allcock, G.H., Flower, R., and Perretti, M. (2001) Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J. Leukoc. Biol. 69, 98-104. (Pubitemid 32095123)
71. Star, R.A., Rajora, N., Huang, J., Stock, R.C., Catania, A., and Lipton, J.M. (1995) Evidence of autocrine modulation of macrophage nitric oxide synthase by α-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. U. S. A. 92, 8016-8020.
72. Herraiz, C., Jimenez-Cervantes, C., Zanna, P., and Garcia-Borron, J.C. (2009) Melanocortin 1 receptor mutations impact differentially on signalling to the cAMP and the ERK mitogen-activated protein kinase pathways. FEBS Lett. 583, 3269-3274.
73. Chai, B., Li, J.Y., Zhang, W., Ammori, J.B., and Mulholland, M.W. (2007) Melanocortin-3 receptor activates MAP kinase via PI3 kinase. Regul. Pept. 139, 115-121.
74. Rodrigues, A.R., Pignatelli, D., Almeida, H., and Gouveia, A.M. (2009) Melanocortin 5 receptor activates ERK1/2 through a PI3K-regulated signaling mechanism. Mol. Cell. Endocrinol. 303, 74-81.
75. Lasaga, M., Debeljuk, L., Durand, D., Scimonelli, T.N., and Caruso, C. (2008) Role of α-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation. Peptides 29, 1825-1835.
76. Lee, D.J., Biros, D.J., and Taylor, A.W. (2009) Injection of an α-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis. Int. Immunopharmacol. 9, 1079-1086.
77. Maaser, C., Kannengiesser, K., Specht, C., Lugering, A., Brzoska, T., Luger, T.A., Domschke, W., and Kucharzik, T. (2006) Crucial role of the melanocortin receptor MC1R in experimental colitis. Gut 55, 1415-1422.
78. Taylor, A.W., Kitaichi, N., and Biros, D. (2006) Melanocortin 5 receptor and ocular immunity. Cell. Mol. Biol. (Noisy-le-grand) 52, 53-59.
79. Catania, A., Ed. (2010) Melanocortins: Multiple Actions and Therapeutic Potential. Landes Bioscience and Springer Science + Business Media, New York.
80. Lipton, J.M. and Catania, A. (1997) Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol. Today 18, 140-145.
81. Patel, H.B., Leoni, G., Montero Melendez, T., Sampaio, A.L.F., and Perretti, M. (2010) Melanocortin control of cell trafficking in vascular inflammation. In Melanocortins: Multiple Actions and Therapeutic Potential. Catania, A., Ed. Landes Bioscience and Springer Science + Business Media, New York. pp. 88-106.
82. Bruce-Keller, A.J. (1999) Microglial-neuronal interactions in synaptic damage and recovery. J. Neurosci. Res. 58, 191-201.
83. Delgado, R., Carlin, A., Airaghi, L., Demitri, M.T., Meda, L., Galimberti, D., Baron, P., Lipton, J.M., and Catania, A. (1998) Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J. Leukoc. Biol. 63, 740-745.
84. Galimberti, D., Baron, P., Meda, L., Prat, E., Scarpini, E., Delgado, R., Catania, A., Lipton, J.M., and Scarlato, G. (1999) α-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-α by microglial cells activated with β-amyloid and interferon γ. Biochem. Biophys. Res. Commun. 263, 251-256.
85. Caruso, C., Durand, D., Schioth, H.B., Rey, R., Seilicovich, A., and Lasaga, M. (2007) Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-γ in astrocytes. Endocrinology 148, 4918-4926.
86. Sasaki, M., Li, B., Lankford, K.L., Radtke, C., and Kocsis, J.D. (2007) Remyelination of the injured spinal cord. Prog. Brain Res. 161, 419-433.
87. Gatti, S., Lonati, C., Sordi, A., and Catania, A. (2010) Protective effects of melanocortins in systemic host reactions. In Melanocortins: Multiple Actions and Therapeutic Potential. Catania, A., Ed. Landes Bioscience and Springer Science + Business Media, New York. pp. 117-125.
88. Martin, L.W. and Lipton, J.M. (1990) Acute phase response to endotoxin: rise in plasma α-MSH and effects of α-MSH injection. Am. J. Physiol. 259, R768-772.
89. Delgado Hernandez, R., Demitri, M.T., Carlin, A., Meazza, C., Villa, P., Ghezzi, P., Lipton, J.M., and Catania, A. (1999) Inhibition of systemic inflammation by central action of the neuropeptide α-melanocyte- stimulating hormone. Neuroimmunomodulation 6, 187-192.
90. Abou-Mohamed, G., Papapetropoulos, A., Ulrich, D., Catravas, J.D., Tuttle, R.R., and Caldwell, R.W. (1995) HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitro. J. Pharmacol. Exp. Ther. 275, 584-591.
91. Lipton, J.M., Ceriani, G., Macaluso, A., McCoy, D., Carnes, K., Biltz, J., and Catania, A. (1994) Antiinflammatory effects of the neuropeptide α-MSH in acute, chronic, and systemic inflammation. Ann. N. Y. Acad. Sci. 741, 137-148.
92. Colombo, G., Gatti, S., Sordi, A., Turcatti, F., Carlin, A., Rossi, C., Lonati, C., and Catania, A. (2007) Production and effects of α-melanocyte-stimulating hormone during acute lung injury. Shock 27, 326-333.
93. Pepys, M.B., Rogers, S.L., and Evans, D.J. (1982) Role of the acute phase response in the Shwartzman phenomenon. Clin. Exp. Immunol. 47, 289-295.
94. Scholzen, T.E., Sunderkotter, C., Kalden, D.H., Brzoska, T., Fastrich, M., Fisbeck, T., Armstrong, C.A., Ansel, J.C., and Luger, T.A. (2003) α-Melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 144, 360-370.
95. Guarini, S., Schioth, H.B., Mioni, C., Cainazzo, M., Ferrazza, G., Giuliani, D., Wikberg, J.E., Bertolini, A., and Bazzani, C. (2002) MC(3) receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion-induced arrhythmias. Naunyn Schmiedebergs Arch. Pharmacol. 366, 177-182.
96. Bazzani, C., Mioni, C., Ferrazza, G., Cainazzo, M.M., Bertolini, A., and Guarini, S. (2002) Involvement of the central nervous system in the protective effect of melanocortins in myocardial ischaemia/reperfusion injury. Resuscitation 52, 109-115.
97. Bazzani, C., Guarini, S., Botticelli, A.R., Zaffe, D., Tomasi, A., Bini, A., Cainazzo, M.M., Ferrazza, G., Mioni, C., and Bertolini, A. (2001) Protective effect of melanocortin peptides in rat myocardial ischemia. J. Pharmacol. Exp. Ther. 297, 1082-1087.
98. Huh, S.K., Lipton, J.M., and Batjer, H.H. (1997) The protective effects of α-melanocyte stimulating hormone on canine brain stem ischemia. Neurosurgery 40, 132-139; discussion 139-140.
99. Huang, Q. and Tatro, J.B. (2002) α-Melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-α and interleukin-1β gene expression following transient cerebral ischemia in mice. Neurosci. Lett. 334, 186-190.
100. Giuliani, D., Mioni, C., Altavilla, D., Leone, S., Bazzani, C., Minutoli, L., Bitto, A., Cainazzo, M.M., Marini, H., Zaffe, D., Botticelli, A.R., Pizzala, R., Savio, M., Necchi, D., Schioth, H.B., Bertolini, A., Squadrito, F., and Guarini, S. (2006) Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 147, 1126-1135.
101. Chiao, H., Kohda, Y., McLeroy, P., Craig, L., Housini, I., and Star, R.A. (1997) α-Melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J. Clin. Invest. 99, 1165-1172.
102. Kwon, T.H., Frokiaer, J., Han, J.S., Knepper, M.A., and Nielsen, S. (2000) Decreased abundance of major Na(+) transporters in kidneys of rats with ischemia-induced acute renal failure. Am. J. Physiol. Renal Physiol. 278, F925-939.
103. Deng, J., Kohda, Y., Chiao, H., Wang, Y., Hu, X., Hewitt, S.M., Miyaji, T., McLeroy, P., Nibhanupudy, B., Li, S., and Star, R.A. (2001) Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int. 60, 2118-2128.
104. Jo, S.K., Yun, S.Y., Chang, K.H., Cha, D.R., Cho, W.Y., Kim, H.K., and Won, N.H. (2001) α-MSH decreases apoptosis in ischaemic acute renal failure in rats: possible mechanism of this beneficial effect. Nephrol. Dial. Transplant. 16, 1583-1591.
105. Chiao, H., Kohda, Y., McLeroy, P., Craig, L., Linas, S., and Star, R.A. (1998) α-Melanocyte-stimulating hormone inhibits renal injury in the absence of neutrophils. Kidney Int. 54, 765-774.
106. Doi, K., Hu, X., Yuen, P.S., Leelahavanichkul, A., Yasuda, H., Kim, S.M., Schnermann, J., Jonassen, T.E., Frokiaer, J., Nielsen, S., and Star, R.A. (2008) AP214, an analogue of α-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality. Kidney Int. 73, 1266-1274.
107. Simmons, M.N., Subramanian, V., Crouzet, S., Haber, G.P., Colombo, J.R., Jr., Ukimura, O., Nielsen, S., and Gill, I.S. (2010) α-Melanocyte stimulating hormone analogue AP214 protects against ischemia induced acute kidney injury in a porcine surgical model. J. Urol. 183, 1625-1629.
108. Lee, Y.S., Park, J.J., and Chung, K.Y. (2008) Change of melanocortin receptor expression in rat kidney ischemia-reperfusion injury. Transplant. Proc. 40, 2142-2144.
109. Colombo, G., Gatti, S., Turcatti, F., Sordi, A., Fassati, L.R., Bonino, F., Lipton, J.M., and Catania, A. (2005) Gene expression profiling reveals multiple protective influences of the peptide α-melanocyte-stimulating hormone in experimental heart transplantation. J. Immunol. 175, 3391-3401.
110. Gatti, S., Colombo, G., Buffa, R., Turcatti, F., Garofalo, L., Carboni, N., Ferla, L., Fassati, L.R., Lipton, J.M., and Catania, A. (2002) α-Melanocyte-stimulating hormone protects the allograft in experimental heart transplantation. Transplantation 74, 1678-1684.
111. Mioni, C., Bazzani, C., Giuliani, D., Altavilla, D., Leone, S., Ferrari, A., Minutoli, L., Bitto, A., Marini, H., Zaffe, D., Botticelli, A.R., Iannone, A., Tomasi, A., Bigiani, A., Bertolini, A., Squadrito, F., and Guarini, S. (2005) Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats. Crit. Care Med. 33, 2621-2628.
112. Catania, A., Lonati, C., Sordi, A., Leonardi, P., Carlin, A., and Gatti, S. (2010) The peptide NDP-MSH induces phenotype changes in the heart that resemble ischemic preconditioning. Peptides 31, 116-122.
113. Murry, C.E., Jennings, R.B., and Reimer, K.A. (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136.
114. Yoshimura, A., Naka, T., and Kubo, M. (2007) SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454-465.
115. Wahl, C., Liptay, S., Adler, G., and Schmid, R.M. (1998) Sulfasalazine: a potent and specific inhibitor of nuclear factor κ B. J. Clin. Invest. 101, 1163-1174.
116. Podolsky, D.K. (2002) Inflammatory bowel disease. N. Engl. J. Med. 347, 417-429.
117. Lee, J.Y., Kim, J.S., Kim, J.M., Kim, N., Jung, H.C., and Song, I.S. (2007) Simvastatin inhibits NF- κB signaling in intestinal epithelial cells and ameliorates acute murine colitis. Int. Immunopharmacol. 7, 241-248.
118. Herfarth, H., Brand, K., Rath, H.C., Rogler, G., Scholmerich, J., and Falk, W. (2000) Nuclear factor-κB activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin. Clin. Exp. Immunol. 120, 59-65.
119. Shibata, W., Maeda, S., Hikiba, Y., Yanai, A., Ohmae, T., Sakamoto, K., Nakagawa, H., Ogura, K., and Omata, M. (2007) Cutting edge: the IκB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis. J. Immunol. 179, 2681-2685.
120. Oktar, B.K., Ercan, F., Yegen, B.C., and Alican, I. (2000) The effect of α-melanocyte stimulating hormone on colonic inflammation in the rat. Peptides 21, 1271-1277.
121. Rajora, N., Boccoli, G., Catania, A., and Lipton, J.M. (1997) α-MSH modulates experimental inflammatory bowel disease. Peptides 18, 381-385.
122. San, T., Oktar, B.K., Salik, E., Ercan, F., and Alican, I. (2001) The effect of α-melanocyte stimulating hormone on endotoxin-induced intestinal injury. Peptides 22, 2077-2082.
123. Hench, P.S., Kendall, E.C., Slocumb, C.H., and Polley, H.E. (1949) The effect of the adrenal cortex (17-hydroxy-11-dehydrocortisone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis; preliminary report. Proc. Staff Meet. Mayo Clin. 24, 181-197.
124. Gutman, A.B. and Yu, T.F. (1950) Effects of ACTH in gout. Am. J. Med. 9, 24-30.
125. Ritter, J., Kerr, L.D., Valeriano-Marcet, J., and Spiera, H. (1994) ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems. J. Rheumatol. 21, 696-699.
126. Schlesinger, N. (2008) Overview of the management of acute gout and the role of adrenocorticotropic hormone. Drugs 68, 407-415.
127. Brzoska, T., Luger, T.A., Maaser, C., Abels, C., and Bohm, M. (2008) α-Melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr. Rev. 29, 581-602.
128. Ceriani, G., Diaz, J., Murphree, S., Catania, A., and Lipton, J.M. (1994) The neuropeptide α-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1, 28-32.
129. Getting, S.J., Christian, H.C., Flower, R.J., and Perretti, M. (2002) Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum. 46, 2765-2775.
130. Getting, S.J., Kaneva, M., Bhadresa, Y., Renshaw, D., Leoni, G., Patel, H.B., Kerrigan, P.M., and Locke, I.C. (2009) Melanocortin peptide therapy for the treatment of arthritic pathologies. TheScientificWorldJOURNAL 9, 1394-1414.
131. Getting, S.J. and Perretti, M. (2001) Arthritic diseases: melanocortin type 3 receptor agonists as potential therapeutics. Curr. Opin. Investig. Drugs 2, 1064-1069.
132. Grassel, S., Opolka, A., Anders, S., Straub, R.H., Grifka, J., Luger, T.A., and Bohm, M. (2009) The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of α-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components. Arthritis Rheum. 60, 3017-3027.
133. Lipton, J.M. (1989) Neuropeptide α-melanocyte-stimulating hormone in control of fever, the acute phase response, and inflammation. In Neuroimmune Networks: Physiology and Diseases. Goetzel, E., Ed. Alan R. Liss, New York. pp. 243-250.
134. Hiltz, M.E. and Lipton, J.M. (1990) α-MSH peptides inhibit acute inflammation and contact sensitivity. Peptides 11, 979-982.
135. Hiltz, M.E., Catania, A., and Lipton, J.M. (1992) α-MSH peptides inhibit acute inflammation induced in mice by rIL- 1 β, rIL-6, rTNF-α and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. Cytokine 4, 320-328.
136. Ceriani, G., Macaluso, A., Catania, A., and Lipton, J.M. (1994) Central neurogenic antiinflammatory action of α-MSH: modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology 59, 138-143.
137. Hiltz, M.E. and Lipton, J.M. (1989) Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide α-MSH. FASEB J. 3, 2282-2284.
138. Luger, T.A., Brzoska, T., Scholzen, T.E., Kalden, D.H., Sunderkotter, C., Armstrong, C., and Ansel, J. (2000) The role of α-MSH as a modulator of cutaneous inflammation. Ann. N. Y. Acad. Sci. 917, 232-238.
139. Luger, T.A., Scholzen, T., Brzoska, T., Becher, E., Slominski, A., and Paus, R. (1998) Cutaneous immunomodulation and coordination of skin stress responses by α-melanocyte-stimulating hormone. Ann. N. Y. Acad. Sci. 840, 381-394.
140. Grabbe, S., Bhardwaj, R.S., Mahnke, K., Simon, M.M., Schwarz, T., and Luger, T.A. (1996) α-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J. Immunol. 156, 473-478.
141. Rheins, L.A., Cotleur, A.L., Kleier, R.S., Hoppenjans, W.B., Saunder, D.N., and Nordlund, J.J. (1989) α-Melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J. Invest. Dermatol. 93, 511-517.
142. Getting, S.J., Riffo-Vasquez, Y., Pitchford, S., Kaneva, M., Grieco, P., Page, C.P., Perretti, M., and Spina, D. (2008) A role for MC3R in modulating lung inflammation. Pulm. Pharmacol. Ther. 21, 866-873.
143. Raap, U., Brzoska, T., Sohl, S., Path, G., Emmel, J., Herz, U., Braun, A., Luger, T., and Renz, H. (2003) α-Melanocyte-stimulating hormone inhibits allergic airway inflammation. J. Immunol. 171, 353-359.
144. Namba, K., Kitaichi, N., Nishida, T., and Taylor, A.W. (2002) Induction of regulatory T cells by the immunomodulating cytokines α-melanocyte- stimulating hormone and transforming growth factor-β2. J. Leukoc. Biol. 72, 946-952.
145. Taylor, A.W., Yee, D.G., Nishida, T., and Namba, K. (2000) Neuropeptide regulation of immunity. The immunosuppressive activity of α-melanocyte- stimulating hormone (α-MSH). Ann. N. Y. Acad. Sci. 917, 239-247.